Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R6BI
|
||||
Former ID |
DAP000254
|
||||
Drug Name |
Fenoldopam
|
||||
Synonyms |
Carlacor; Fenoldopamum; Fenodopam mesylate; Fenoldopamum [Latin]; SKF 82526; Carlacor (TN); Corlopam (TN); Fenoldopam (INN);Fenoldopam [INN:BAN]; SKF 82526-J; SKF-82526J; SK&F-82526; 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol; 9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Approved | [1], [2] | ||
Therapeutic Class |
Antihypertensive Agents
|
||||
Company |
Ben Venue Laboratories
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H16ClNO3
|
||||
InChI |
InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2/t13-/m1/s1
|
||||
InChIKey |
TVURRHSHRRELCG-CYBMUJFWSA-N
|
||||
CAS Number |
CAS 67227-57-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:5002
|
||||
SuperDrug ATC ID |
C01CA19
|
||||
SuperDrug CAS ID |
cas=067227569
|
||||
Target and Pathway | |||||
Target(s) | Dopamine D1 receptor | Target Info | Agonist | [3] | |
KEGG Pathway | Calcium signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Dopaminergic synapse | |||||
Parkinson's disease | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Morphine addiction | |||||
Alcoholism | |||||
PANTHER Pathway | Dopamine receptor mediated signaling pathway | ||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
Reactome | Dopamine receptors | ||||
G alpha (s) signalling events | |||||
WikiPathways | Hypothetical Network for Drug Addiction | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Genes and (Common) Pathways Underlying Drug Addiction | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 985). | ||||
REF 3 | Etiology of iodinated radiocontrast nephrotoxicity and its attenuation by beraprost. Yakugaku Zasshi. 2008 Jul;128(7):1023-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.